Key facts
- It has raised $50K; the latest was Angel (individual) ($50K) in Nov 2025.
- Notable investors include Harvard Business School, Oliver Haarmann.
- Status: Privately Held (backing).
Investors
2- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for smartSTAT
- ·The full record, as it builds
Funding rounds
No funding rounds for smartSTAT are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About smartSTAT
Developer of an emergency medication and supply cart system designed to improve accuracy, readiness, and operational efficiency. The company's system is equipped with radio frequency identification-based item tagging, continuous inventory monitoring, centralized dashboard access, automated tracking of medication quantities and expiration dates, emergency mode visibility, configurable cart layouts, and data reporting for clinical and supply chain teams, enabling healthcare professionals to reduce manual inventory checks, minimize expired or missing emergency supplies, and improve patient safety during critical events.
- Sector
- Healthcare
- HQ
- Boston, MA, United States
- Website
- smartstat.io/
- Ownership
- Privately Held (backing)
smartSTAT doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in smartSTAT shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on smartSTAT in its N-PORT filings yet. We sweep new filings monthly.